In fact, neuropathological research has shown that striatal tyrosine hydroxylase and DAT staining are drastically reduced within 4-5 years of PD onset [8], meaning that dopaminergic imaging is less effective for tracking late-stage PD progression. The gene discussed is SLC6A3; the disease is Parkinson disease.